STAT

STAT+: Pharmalittle: We’re reading about drug price hikes, Bayer strategic moves, and more

Drug companies raised list prices on 775 brand-name drugs during the first half of January, including popular GLP-1 medicines Ozempic and Mounjaro.
Source: Alex Hogan/STAT

Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will draw on a

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Element Biosciences, An Illumina Rival, On Its Genomics Ambitions — And Why It Hasn’t Gone Public
Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.
STAT1 min read
Genetic Variant Common Among West African Descendants Contributes To Large Cardiovascular Disease Burden
A new study in JAMA identifies a genetic variant commonly found in people of West African descent that raises a type of cardiovascular disease risk.
STAT1 min read
STAT+: Pharmalittle: We’re Watching BIO Layoffs, AstraZeneca Plans To Double Revenue, And More
The Biotechnology Innovation Organization on Monday announced 30 layoffs that are part of a restructuring.

Related Books & Audiobooks